The Vascular Endothelial Growth Factors-Expressing Character of Mesenchymal Stem Cells Plays a Positive Role in Treatment of Acute Lung Injury In Vivo

Figure 7

The cytokine levels in the LPS injured lung after the MSC, MSC-GFP, or MSC-ShVEGF treatment by ELISA. (a) IL-1β levels in the LPS injured lung in different groups at 1, 6, and 24 hours after cells treatment measured by ELISA. (b) IL-10 levels in the LPS injured lung in different groups at 1, 6, and 24 hours after cells treatment measured by ELISA (; versus control group, versus ALI + PBS group, and versus ALI + MSC group).

(a)

(b)